Generex Biotechnology granted new U.S. drug delivery patent
Patent covers broad claims for the delivery of macromolecules via the buccal cavity of the mouth
The patent relates to the Company's proprietary methodologies for the production of safe and effective oral formulations for the delivery of macromolecular pharmaceutical agents into the human body via the buccal region of the mouth. The process involves the creation of a stable mixed micellar solution containing the pharmaceutical agent, absorption enhancers, and other excipients. When the solution is introduced to the buccal mucosa, the result is increased bioavailability of the active drug and more rapid onset of action.
Most read news
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.